Gemcitabine and cisplatin combined with the Chinese herbal medicine compound Fuzhenggubenfang improve quality of life and progression-free survival in patients with advanced non-small cell lung cancer

Journal Title: Traditional Medicine Research - Year 2018, Vol 3, Issue 1

Abstract

Objective: To assess the role of chemotherapy combined with the compound Chinese herbal medicine, Fuzhenggubenfang (FZGBF), for treating advanced non-small-cell lung cancer. Methods: A total of 84 eligible patients were enrolled from October 2013 to July 2016. Patients were randomized to receive either chemotherapy alone as the control group or chemotherapy combined with FZGBF as the experimental group. The primary endpoint of the study was quality of life (QOL) and progression-free survival (PFS). Secondary endpoints were tumor response rate, toxicity, dropout rate, and univariate and multivariate analyses of clinicopathologic factors for QOL and PFS. Results: There was a significant improvement in QOL, including better overall health (P < 0.001), physical function (P < 0.001), role function (P < 0.001), emotional function (P < 0.001), cognitive function (P < 0.001), and social function (P = 0.031). Less fatigue, nausea or vomiting, insomnia, appetite loss, constipation, and alopecia were noted (All P < 0.001) when FZGBF was combined with chemotherapy in comparison to chemotherapy alone. The experimental group had a better PFS compared with the control group (P = 0.032). There was no significant difference in tumor response rate. FZGBF significantly reduced chemotherapy-induced anemia (P < 0.001), neutropenia (P = 0.023), nausea and vomiting (P < 0.001). The use of Chinese herbal compounds had only mild side effects. In this study, factors influencing QOL were the use of the Chinese herbal compounds (P < 0.001), performance status score (P = 0.027), clinical staging of cancer (P = 0.009), and sex (P = 0.044). Use of traditional Chinese medicine (P = 0.043) and the number of previous chemotherapy sessions (P = 0.003) were the factors influencing PFS in this study. Conclusion: FZGBF could improve QOL, compliance to treatment, relieved chemotherapy-related toxicities of patients, and consequently improved PFS, which is a promising drug combination in complementary medicine for the treatment of advanced NSCLC.

Authors and Affiliations

Dong-Mei Jiang, Feng-Wei Wang, Li-Juan Zhang, Long Zhang, Tai Zhang, Wen-Hua Zhang

Keywords

Related Articles

Fireneedle up-regulates the expression of ERK1/2 in neural stem cells

Objective: To explore the effect of fire needle on the expression of ERK1/2 of neural stem cells (NSCs) obtained from rats with spinal cord injury (SCI). Methods: Sixty SD female rats were randomly divided into 5 groups,...

Rat model for study of the essence of spleen deficiency and dampness in Chinese medicine

Objective: To explore the essence of spleen deficiency and dampness in Chinese medicine by successfully constructing a rat model with this syndrome. Methods: Rat models with the syndrome of dampness and spleen deficiency...

Ban Xia Lian Qiao Tang

Composition Jiang Ban Xia (Rhizome Pinelliae Fermentata) 30g, Lian Qiao (Fructus Forsythiae) 30g Directions The herbs are decocted with 500ml water and concentrated to 200ml. The patients between the ages of five a...

Clinical effects of digital acupoint pressure combined with hot ironing for scapulohumeral periarthritis in Zhuang medicine

Objective: To observe the clinical effect of digital acupoint pressure combined with hot ironing of Zhuang medicine in the therapy of scapulohumeral periarthritis. Methods: 160 patients with scapulohumeral periarthritis...

Pharmacological intervention of traditional Chinese medicine for the quality of life in patients with colorectal cancer: a systematic review and meta-analysis

Objective: The objective of this study is to evaluate the impact of various traditional Chinese medicine (TCM) approaches on the quality of life in patients with colorectal cancer. Methods: In this study, we systematical...

Download PDF file
  • EP ID EP45246
  • DOI 10.12032/TMR201809063
  • Views 264
  • Downloads 0

How To Cite

Dong-Mei Jiang, Feng-Wei Wang, Li-Juan Zhang, Long Zhang, Tai Zhang, Wen-Hua Zhang (2018). Gemcitabine and cisplatin combined with the Chinese herbal medicine compound Fuzhenggubenfang improve quality of life and progression-free survival in patients with advanced non-small cell lung cancer. Traditional Medicine Research, 3(1), -. https://europub.co.uk/articles/-A-45246